Repligen was recognized as a critical supplier for COVID-19 vaccine development. The team at the Rancho Dominguez Center of Excellence played a vital role in the successful production of over 500 million COVID-19 vaccines for a major manufacturer. We are proud of the part we play in the effort to end the pandemic.
Repligen向您推荐用于疫苗开发和生产的、针对SARS CoV-2刺突蛋白纯化的新型亲和填料。NGL COVID-19刺突蛋白亲和填料结合SARS-CoV-2 刺突蛋白受体结合结构域(RBD),可在单个层析步骤中,获得出色的纯度。该填料可使用经质量确认的现货 OPUS® 预装柱 形式提供,以方便使用,也提供“散装”填料形式。
Rapid response with COVID-19 prioritized lead times
Proven technologies with broad customer base from clinical to commercial = reduced risk
Adoption in diverse platforms including mAbs, proteins, viruses, plasmids, AAV, Lentivirus, mRNA
Expert-guided priority support for rapid technology implementation
Leading technologies for upstream process intensification, downstream processing, process analytics - scalable from bench to production scale
Closed, single-use bioprocessing — single-use, Gamma-irradiated, fully integrated flow paths
Configurable, sterile assemblies
Reduced installation time
High capacity rPA affinity resin
at a fraction of the cost
Configurable, sterile assemblies
Reduced installation time
Needs and Challenges
Downstream solutions
Needs and Challenges
Upstream solutions
Downstream solutions
Needs and Challenges
Upstream solutions
Downstream solutions
Upstream solutions
Downstream solutions
OPUS® Columns with Purolite Protein A Resin
High capacity rPA affinity resin at a fraction of the cost
Spectrum® Hollow Fiber TFF Filters
Low shear TFF,
1400 configurations
Closed, Gamma-irradiated, no cleaning validation